eLearning module: The analytics
This expert authored eLearning module focuses on the importance of analytical data during the development process of biosimilars. It also provides a brief overview of the data requirements for approval of these products in Europe.
This module will take up to 20 minutes to complete.
On completion of the eLearning module, you will be able to:
- Describe how analytical data is utilized in the development of biosimilars.
- Understand the importance of analytics in the EMA approval of biosimilars.
All medical oncologists, specialist nurses, and allied healthcare professionals working with patients for whom biosimilars may represent a treatment option.